Chromatin modifiers and the promise of epigenetic therapy in acute leukemia von Greenblatt, S M, Nimer, S D

Volltext

Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective von Alkhatib, Nimer S, Almutairi, Abdulaali R, Almadi, Majid, Halloush, Shiraz, Al-Ruthia, Yazed Sulaiman H, Rashdan, Omar, Al-Shatnawi, Samah, Azzam, Nahla A, Mosli, Mahmoud H, Badawoud, Amal M, Al Yami, Majed S, Alhossan, Abdulaziz, AlHarbi, Ibtisam

Volltext

Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1 von Kalakonda, N, Fischle, W, Boccuni, P, Gurvich, N, Hoya-Arias, R, Zhao, X, Miyata, Y, MacGrogan, D, Zhang, J, Sims, J K, Rice, J C, Nimer, S D

Volltext

Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML von Kaushik, S, Liu, F, Veazey, K J, Gao, G, Das, P, Neves, L F, Lin, K, Zhong, Y, Lu, Y, Giuliani, V, Bedford, M T, Nimer, S D, Santos, M A

Volltext

Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan von Halawah, Hala H., Alkhatib, Nimer S., Almutairi, Abdulaali R., Saleh, Mohammad, Halloush, Shiraz S., Rashdan, Omar, Masadh, Lama, Abusara, Osama H., Abraham, Ivo

Volltext

The Importance of Outcome and Precise Evaluation in Economic Analysis of Cancer Drugs—Reply von Almutairi, Abdulaali R, Alkhatib, Nimer S, Abraham, Ivo

Volltext

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma von Almutairi, Abdulaali R, Alkhatib, Nimer S, Oh, Mok, Curiel-Lewandrowski, Clara, Babiker, Hani M, Cranmer, Lee D, McBride, Ali, Abraham, Ivo

Volltext

Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective von Halloush, Shiraz, Alkhatib, Nimer S., Almutairi, Abdulaali R., Calamia, Mathias, Halawah, Hala, Obeng-Kusi, Mavis, Hoyle, Martin, Rashdan, Omar, Koeller, Jim, Abraham, Ivo

Volltext

Loss of p300 accelerates MDS-associated leukemogenesis von Cheng, G, Liu, F, Asai, T, Lai, F, Man, N, Xu, H, Chen, S, Greenblatt, S, Hamard, P-J, Ando, K, Chen, X, Wang, L, Martinez, C, Tadi, M, Wang, L, Xu, M, Yang, F-C, Shiekhattar, R, Nimer, S D

Volltext

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS von List, A F, Bennett, J M, Sekeres, M A, Skikne, B, Fu, T, Shammo, J M, Nimer, S D, Knight, R D, Giagounidis, A

Volltext

The economic impact of tobacco smoking and secondhand smoke exposure in Jordan: estimating the direct and indirect costs von Alkhatib, Nimer S, Massad, Eman, Rashdan, Omar, Max, Wendy, Halloush, Shiraz, Abumansour, Hamza, Alkhatib, Ala'a, Karasneh, Reema A, Al-Shatnawi, Samah, Qirim, Tariq, Hawari, Feras, Alkhatib, Said

Volltext

Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective von Alkhatib, Nimer S., Almutairi, Abdulaali R., Alkhezi, Omar S., Alfayez, Osama M., Al Yami, Majed S., Almohammed, Omar A.

Volltext

Pricing methods in outcome-based contracting: δ2: willingness-to-pay-based pricing von Alkhatib, Nimer S., Ramos, Kenneth, Erstad, Brian, Slack, Marion, McBride, Ali, Bhattacharjee, Sandipan, Abraham, Ivo

Volltext

Pricing methods in outcome-based contracting: δ1: cost effectiveness analysis and cost-utility analysis-based pricing von Alkhatib, Nimer S., Ramos, Kenneth, Erstad, Brian, Slack, Marion, McBride, Ali, Bhattacharjee, Sandipan, Abraham, Ivo

Volltext

Pricing methods in outcome-based contracting: δ3: reference-based pricing von Alkhatib, Nimer S., Erstad, Brian, Ramos, Kenneth, McBride, Ali, Bhattacharjee, Sandipan, Slack, Marion, Abraham, Ivo

Volltext

A systematic review, meta-analysis, and meta-regression of the prevalence of self-reported disordered eating and associated factors among athletes worldwide von Ghazzawi, Hadeel A, Nimer, Lana S, Haddad, Areen Jamal, Alhaj, Omar A, Amawi, Adam T, Pandi-Perumal, Seithikurippu R, Trabelsi, Khaled, Seeman, Mary V, Jahrami, Haitham

Volltext

Pricing methods in outcome-based contracting: integration analysis of the six dimensions (6 δs) von Alkhatib, Nimer S., McBride, Ali, Slack, Marion, Bhattacharjee, Sandipan, Erstad, Brian, Ramos, Kenneth, Abraham, Ivo

Volltext

The global prevalence of screen-based disordered eating and associated risk factors among high school students: systematic review, meta-analysis, and meta-regression von Ghazzawi, Hadeel A, Nimer, Lana S, Sweidan, Dima H, Alhaj, Omar A, Abulawi, Duha, Amawi, Adam T, Levine, Michael P, Jahrami, Haitham

Volltext

Pricing methods in outcome-based contracting: δ5: risk of efficacy failure-based pricing von Alkhatib, Nimer S., McBride, Ali, Bhattacharjee, Sandipan, Ramos, Kenneth, Erstad, Brian, Slack, Marion, Billheimer, Dean, Abraham, Ivo

Volltext

Pricing methods in outcome-based contracting: δ6: adherence-based pricing von Alkhatib, Nimer S., Slack, Marion, Bhattacharjee, Sandipan, Erstad, Brian, Ramos, Kenneth, McBride, Ali, Abraham, Ivo

Volltext